WMS Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

WMS Partners’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$2K	–	204
2018 Q4	$2K	Buy	+20,000	New	+$13.1K	﹤0.01%	183

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

WMS Partners's SGYP Position: Q1 2019 in Review

WMS Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 20,000 shares — an estimated $2K sold.

WMS Partners first reported a position in SGYP in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

WMS Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
WMS Partners sold 20,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
WMS Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2018 and held it in 1 quarter.
WMS Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2K in Q4 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on WMS Partners's 13F filing for Q1 2019, filed 13 May 2019.